Franz X. Vollenweider

Citée par

	Toutes	Depuis 2020
Citations	25457	11829
indice h	82	56
indice i10	157	113

2900

1450

725

2175

20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025143 299 271 447 377 443 413 533 546 541 661 699 839 880 700 901 890 993 1309 1059 1555 1986 2384 2673 2882 318

Accès public

Tout afficher

55 articles

2 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Katrin PrellerUniversity of ZurichAdresse e-mail validée de bli.uzh.ch
Michael KometerUnknown affiliationAdresse e-mail validée de bli.uzh.ch
Erich SeifritzProfessor of Psychiatry, University of ZürichAdresse e-mail validée de bli.uzh.ch
Mark A GeyerProfessor of Psychiatry, University of California San DiegoAdresse e-mail validée de ucsd.edu
André SchmidtUniversity of Basel, Department of Psychiatry (UPK)Adresse e-mail validée de unibas.ch
Boris B. QuednowProfessor Pharmakopsychologie, Universität ZürichAdresse e-mail validée de bli.uzh.ch
Erich StuderusLecturer and researcher at the University of Applied Sciences Northwestern SwitzerlandAdresse e-mail validée de fhnw.ch
Daniel Umbrichtxperimed GmbHAdresse e-mail validée de xperimed.com
Alan AnticevicCEO @ Manifest Technologies, Former Glenn H. Greenberg Associate Professor, Yale UniversityAdresse e-mail validée de manifesttech.io
Jie Lisa JiYale UniversityAdresse e-mail validée de yale.edu
Joram FeldonETH-zAdresse e-mail validée de behav.biol.ethz.ch
Olivia CarterUniversity of MelbourneAdresse e-mail validée de unimelb.edu.au
Milan ScheideggerDepartment of Psychiatry, Psychotherapy and Psychosomatics (DPPP), University of ZurichAdresse e-mail validée de bli.uzh.ch
John KrystalRobert L. McNeil, Jr., Professor of Translational Research, Chair of Psychiatry, Yale UniversityAdresse e-mail validée de yale.edu
Grega RepovšAssociate Professor of Psychology, University of LjubljanaAdresse e-mail validée de psy.ff.uni-lj.si
John D. MurrayGregg L. Engles Associate Professor of Psychological and Brain Sciences, Dartmouth CollegeAdresse e-mail validée de dartmouth.edu
Marcus HerdenerUniversity of ZurichAdresse e-mail validée de bli.uzh.ch
Adeel RaziAssociate Professor, Monash University, AusraliaAdresse e-mail validée de monash.edu
Guy WallisUniversity of QueenslandAdresse e-mail validée de uq.edu.au
Flora MoujaesUniversity of ZurichAdresse e-mail validée de bli.uzh.ch

Suivre

Franz X. Vollenweider

Professor of Psychiatry, University of Zürich

Adresse e-mail validée de bli.uzh.ch - Page d'accueil

Neuropsychopharmacology foundation of consciousness models of psychosis neurobiology of psychedlics hallucinogens


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action FX Vollenweider, MFI Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, ... Neuroreport 9 (17), 3897-3902, 1998	1193	1998
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders FX Vollenweider, M Kometer Nature Reviews Neuroscience 11 (9), 642, 2010	895	2010
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia D Umbricht, L Schmid, R Koller, FX Vollenweider, D Hell, DC Javitt Archives of general psychiatry 57 (12), 1139-1147, 2000	728	2000
Psychometric evaluation of the altered states of consciousness rating scale (OAV) E Studerus, A Gamma, FX Vollenweider PloS one 5 (8), e12412, 2010	713	2010
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies E Studerus, M Kometer, F Hasler, FX Vollenweider Journal of psychopharmacology 25 (11), 1434-1452, 2011	632	2011
Psychological and cardiovascular effects and short-term sequelae of MDMA (“ecstasy”) in MDMA-naıve healthy volunteers FX Vollenweider, A Gamma, M Liechti, T Huber Neuropsychopharmacology 19 (4), 241-251, 1998	629	1998
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study F Hasler, U Grimberg, MA Benz, T Huber, FX Vollenweider Psychopharmacology 172, 145-156, 2004	583	2004
Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis FX Vollenweider, KL Leenders, C Scharfetter, P Maguire, O Stadelmann, ... Neuropsychopharmacology 16 (5), 357-372, 1997	553	1997
Serotonin research: contributions to understanding psychoses MA Geyer, FX Vollenweider Trends in pharmacological sciences 29 (9), 445-453, 2008	542	2008
Acute effects of lysergic acid diethylamide in healthy subjects Y Schmid, F Enzler, P Gasser, E Grouzmann, KH Preller, FX Vollenweider, ... Biological psychiatry 78 (8), 544-553, 2015	512	2015
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission … FX Vollenweider, KL Leenders, I Øye, D Hell, J Angst European Neuropsychopharmacology 7 (1), 25-38, 1997	490	1997
Gender differences in the subjective effects of MDMA ME Liechti, A Gamma, FX Vollenweider Psychopharmacology 154, 161-168, 2001	478	2001
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders FX Vollenweider, KH Preller Nature Reviews Neuroscience 21 (11), 611-624, 2020	463	2020
Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F] fluorodeoxyglucose (FDG) FX Vollenweider, KL Leenders, C Scharfetter, A Antonini, P Maguire, ... European neuropsychopharmacology 7 (1), 9-24, 1997	451	1997
A systems model of altered consciousness: integrating natural and drug-induced psychoses FX Vollenweider, MA Geyer Brain research bulletin 56 (5), 495-507, 2001	448	2001
The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation KH Preller, M Herdener, T Pokorny, A Planzer, R Kraehenmann, ... Current Biology 27 (3), 451-457, 2017	442	2017
Prediction of psilocybin response in healthy volunteers E Studerus, A Gamma, M Kometer, FX Vollenweider PloS one 7 (2), e30800, 2012	417	2012
5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man—a PET study with [11C] raclopride FX Vollenweider, P Vontobel, D Hell, KL Leenders Neuropsychopharmacology 20 (5), 424-433, 1999	397	1999
Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations M Kometer, A Schmidt, L Jäncke, FX Vollenweider Journal of Neuroscience 33 (25), 10544-10551, 2013	391	2013
Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers R Kraehenmann, KH Preller, M Scheidegger, T Pokorny, OG Bosch, ... Biological psychiatry 78 (8), 572-581, 2015	375	2015

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs